ias - Monitoring
  • KI-Tools
  • Suche
  • Publizieren
  • Mediathek
Seite wählen
AbbVie, Bristol-Myers Among Patient Advocacy Groups’ Big Backers

AbbVie, Bristol-Myers Among Patient Advocacy Groups’ Big Backers

von Tobias Borgers | Okt. 8, 2019 | Abbvie

AbbVie Inc. , Bristol-Myers Squibb Co., Pfizer Inc., and three other major pharmaceutical companies funneled more than $680 million into hundreds of nonprofits last year, including many now campaigning against federal legislation to tackle the rising cost of medicine....
Global Thrombocytopenia Management Market 2019 – Amarillo Biosciences, Amgen, Baxalta, Bayer, BioLineRx, Boehringer Ingelheim, Bolder Biotechnology

Global Thrombocytopenia Management Market 2019 – Amarillo Biosciences, Amgen, Baxalta, Bayer, BioLineRx, Boehringer Ingelheim, Bolder Biotechnology

von Tobias Borgers | Okt. 8, 2019 | Boehringer

Global Thrombocytopenia Management Market 2019 report contains wide-extending measurable details of Global Thrombocytopenia Management Market, which enables the customer to separate the future maneuver and anticipate right execution.  A comprehensive theory of the...
Pharmaceutical Packaging Equipment Market to Observe Strong Development by 2020 – Space Market Research

Pharmaceutical Packaging Equipment Market to Observe Strong Development by 2020 – Space Market Research

von Tobias Borgers | Okt. 8, 2019 | Bosch

Get Sample Copy of this report at https://www.persistencemarketresearch.com/samples/3037?source=atm The packaging of pharmaceutical products and drug delivery systems is an essential step in the pharmaceutical industry. Pharmaceutical packaging equipment provides...
Pharmaceutical Packaging Equipment Market to Observe Strong Development by 2020 – Space Market Research

Global Fruit and Vegetable Processing Market 2019 Research Analysis – Bosch Packaging Technology, Buhler, Campbell Soup

von Tobias Borgers | Okt. 8, 2019 | Bosch

Recent research analysis from Fior Markets titled Global Fruit and Vegetable Processing Market Growth (Status and Outlook) 2019-2024 clarifies the past movement and patterns considering past encounters to offer a future estimate with respect to different components...
Novartis‘ new eye drug undercuts Bayer’s rival with fewer injections –

Novartis‘ new eye drug undercuts Bayer’s rival with fewer injections –

von Tobias Borgers | Okt. 8, 2019 | Bayer

The FDA has approved Novartis’s new eye drug brolucizumab for wet age-related macular degeneration, which will match Bayer’s rival Eylea on price per dose but reduce costs with a less frequent dosing regimen.Novartis’ Beovu (brolucizumab) has matched the performance...
« Ältere Einträge
Nächste Einträge »

Kategorien

Schlagwörter

Breaking News Kunden Location Production Products prozesstechnik online Wettbewerb
  • Backend
  • Alle Beiträge
  • Dokumentation
  • Logout